InvestorsHub Logo
Post# of 253160
Next 10
Followers 840
Posts 120470
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 181846

Friday, 04/24/2015 4:53:51 PM

Friday, April 24, 2015 4:53:51 PM

Post# of 253160
LLY—FDA approves new Cyramza indication—second-line CRC in conjunction with FOLFIRI:

http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm444496.htm

Cyramza is the “fully human Erbitux” LLY acquired in the 2008 buyout of ImClone.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.